FDA.reportPublic FDA data

NDC 54288-840-25

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC
54288-840-25
Product root
54288-840
Identity scope
Package
Primary current NDC product row
Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
compounderpackage54288-84054288-840-25COMPOUNDEROutsourcing facility compounded drug report2025-22026-08-03

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCProductActive ingredientsReporting periodNormalization
BPI Labs LLC07862762054288-84054288-840-25Tirzepatide30 mg/3 mL2025-2valid